These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25227802)

  • 1. Synergistic effect of ethaselen and selenite treatment against A549 human non-small cell lung cancer cells.
    Xu W; Ma WW; Zeng HH
    Asian Pac J Cancer Prev; 2014; 15(17):7129-35. PubMed ID: 25227802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
    Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
    Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
    Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation.
    Zheng X; Zhang Y; Zhang L; Xu W; Ma W; Sun R; Zeng H
    Biomed Pharmacother; 2016 Oct; 83():212-220. PubMed ID: 27372405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen.
    Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H
    Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model.
    Ye SF; Li J; Ji SM; Zeng HH; Lu W
    Acta Pharmacol Sin; 2017 Feb; 38(2):223-232. PubMed ID: 27917873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of apoptosis in prostate cancer cell line PC-3 by BBSKE, a novel organoselenium compound, and its effect in vivo].
    Shi CJ; Zeng HH; Li HW; Yang FG; Wu XQ; Yu LZ
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1984-8. PubMed ID: 14703435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest.
    Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH
    Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo.
    Xing F; Li S; Ge X; Wang C; Zeng H; Li D; Dong L
    Oral Oncol; 2008 Oct; 44(10):963-9. PubMed ID: 18282784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway.
    Lan L; Zhao F; Wang Y; Zeng H
    Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
    Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
    Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
    Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
    BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis and autophagy by sodium selenite in A549 human lung carcinoma cells through generation of reactive oxygen species.
    Park SH; Kim JH; Chi GY; Kim GY; Chang YC; Moon SK; Nam SW; Kim WJ; Yoo YH; Choi YH
    Toxicol Lett; 2012 Aug; 212(3):252-61. PubMed ID: 22721804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy.
    Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH
    Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione-dependent cell cycle G1 arrest and apoptosis induction in human lung cancer A549 cells caused by methylseleninic acid: comparison with sodium selenite.
    Okuno T; Honda E; Arakawa T; Ogino H; Ueno H
    Biol Pharm Bull; 2014; 37(11):1831-7. PubMed ID: 25177040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro antiproliferative evaluation of novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone.
    Jing F; Fu X; Li S; Li B; Zhao J; Wang X; Liu Y; Chen B
    Chem Pharm Bull (Tokyo); 2015; 63(6):431-7. PubMed ID: 26027467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo.
    Tan Q; Li J; Yin HW; Wang LH; Tang WC; Zhao F; Liu XM; Zeng HH
    Invest New Drugs; 2010 Jun; 28(3):205-15. PubMed ID: 19271154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Anaplerotic Glutaminolysis Underlies Selenite Toxicity in Human Lung Cancer.
    Bruntz RC; Belshoff AC; Zhang Y; Macedo JKA; Higashi RM; Lane AN; Fan TW
    Proteomics; 2019 Nov; 19(21-22):e1800486. PubMed ID: 31298457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method].
    He Y; Wang JS; Zhang P; Zhang WJ; Huang QL; Hua ZC
    Yao Xue Xue Bao; 2013 Jan; 48(1):45-51. PubMed ID: 23600140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.